Expression of the Surface Glycoproteins of Human Parainfluenza Virus Type 3 by Bovine Parainfluenza Virus Type 3, a Novel Attenuated Virus Vaccine Vector

Bovine parainfluenza virus type 3 (bPIV3) is being evaluated as an intranasal vaccine for protection against human PIV3 (hPIV3). In young infants, the bPIV3 vaccine appears to be infectious, attenuated, immunogenic, and genetically stable, which are desirable characteristics for an RNA virus vector....

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Haller, Aurelia A., Miller, Tessa, Mitiku, Misrach, Coelingh, Kathleen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112444/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11090161/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.24.11626-11635.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!